REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/28/2025
Back to search
Official data from USPTO
OTREXUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
06/29/2025
Trademark type
Word
Nice classes
5
Filing date
12/14/2012
Registration date
06/28/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/11/2023
Last transaction
06/29/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2014-01-00
First use in commerce
2014-01-00
Drawing code
4
Owner type
16
Owner location
LAKE FOREST, IL
Examiner
HUGHITT, ELIZABETH
Law office
M20
Current location
TMO LAW OFFICE 111
Holders and representatives
Holders
OTTER PHARMACEUTICALS, LLC
Antares Pharma Inc.
Representatives
Tim Burgdorf
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-arthritic compositions and preparations; chemical preparations for pharmaceutical or medical purposesfor treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the treatment and prevention of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseasesrheumatoid arthritisjuvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for auto immune diseases and inflammatory diseases; pharmaceutical preparations for auto immune diseases and inflammatory diseasesarthritisjuvenile idiopathic arthritis and psoriasis; pharmaceutical products for the treatment of joint disease
Publications
History of USPTO decisions and trademark events.
50 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/11/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/11/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/11/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/24/2022
E815
TEAS SECTION 8 & 15 RECEIVED
06/27/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/28/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/28/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/25/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/24/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/23/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/22/2016
IUAF
USE AMENDMENT FILED
04/27/2016
EISU
TEAS STATEMENT OF USE RECEIVED
04/27/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/27/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/01/2015
PUBO
PUBLISHED FOR OPPOSITION
09/01/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/12/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/30/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/20/2015
EXPT
EXPARTE APPEAL TERMINATED
07/17/2015
EXDM
EXPARTE APPEAL DISMISSED AS MOOT
07/17/2015
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
04/23/2015
GECD
ACTION DENYING REQ FOR RECON E-MAILED
04/23/2015
CNCF
ACTION CONTINUING FINAL - COMPLETED
04/23/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/16/2015
ALIE
ASSIGNED TO LIE
04/10/2015
EXPI
EX PARTE APPEAL-INSTITUTED
04/08/2015
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/08/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/07/2015
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
04/07/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/22/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/22/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/07/2014
GNFR
FINAL REFUSAL E-MAILED
10/07/2014
CNFR
FINAL REFUSAL WRITTEN
10/07/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/25/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/24/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/24/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/24/2014
GNRT
NON-FINAL ACTION E-MAILED
03/24/2014
CNRT
NON-FINAL ACTION WRITTEN
03/24/2014
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/23/2013
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/20/2013
GNSL
LETTER OF SUSPENSION E-MAILED
03/20/2013
CNSL
SUSPENSION LETTER WRITTEN
03/20/2013
DOCK
ASSIGNED TO EXAMINER
03/18/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/02/2013
NWAP
NEW APPLICATION ENTERED
12/18/2012
Continuous trademark protection
Get notified about every new filing that threatens OTREXUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.